Neovasc (NVCN) Announces First Implant of its Reducer in U.S. Patient
Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)